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ABSTRACT
Objective: The treatment of symptomatic carotid-cavernous fistulas [CCF] has been historically treated in the devel-
oped world through the endovascular route. We report our first case of using a covered stent in a patient with spontane-
ous CCF. Method: Single patient with spontaneous indirect high flow CCF treated with a covered stent. We present 
retrospective analysis of technical success, initial and 6-month follow-up angiography and clinical outcome. Result: 
The stent was successfully navigated and deployed covering the CCF orifice. Immediate post stent deployment angiog-
raphy showed marked reduction in flow and complete occlusion at 6-months. Clinically, patient showed near-complete 
recovery at 6 months. Conclusion: With proper neuroendovascular training and experience, use of a covered stent is 
cost effective and feasible for the treatment of CCFs in under developed countries. 
Key Words: Carotid-cavernous fistula, spontaneous, endovascular treatment, Covered stents. 
C A S E  R E P O R T
INTRODUCTION
Abnormal communication between the carotid arterial 
system and cavernous sinus results in Carotid Cavern-
ous Fistula [CCF]. Iatrogenic damage [trans-sphenoidal 
surgery, glycerol rhizotomy etc] as well as blunt and 
penetrating head trauma may lead to direct CCF (1-2). 
CCFs not associated with history of trauma are regarded 
as spontaneous. Conditions that weaken the Internal 
Carotid Artery [ICA] wall can lead to spontaneous CCF. 
Predisposing conditions include rupture of carotid 
cavernous aneurysm, atherosclerosis, connective tissue 
disorders like Ehlers-Danlos syndrome, fibromuscular 
dysplasia and pseudoxanthoma elasticum (3-7). Treat-
ment modalities include conservative approach i.e. 
manual compression therapy, surgical management 
[carotid ligation], stereotactic radiosurgery and endovas-
cular management encompassing either or combination 
of transarterial and transvenous approaches. Endovas-
cular transarterial technique employing reconstructive 
approach with a covered stent has shown impressive 
results. This technique reduces the procedure time and 
cost by covering the fistula ostium (8-11). The purpose of 
our study was to present our preliminary experience and 
feasibility of using a covered stent for CCF treatment. 
TECHNIQUE
A 35-year-old man sought medical attention with a few 
weeks history of gradually progressive conjunctiva and 
episcleral vessel venous congestion, visual blurring and 
exophthalmos. His detailed ophthalmologic examination 
had earlier shown elevated intraocular pressure. Prior to 
the procedure, patient had received coated Aspirin 
[75mg/d] and Clopidogrel [75mg/d] for 5 consecutive 
days. The procedure was performed under general anes-
thesia. After a 6-F guide catheter was positioned in the 
distal right carotid artery, the initial diagnostic angiogra-
phy showed an indirect right CCF (12). [Barrow’s Classifi-
cation – Type D]. The arterial supply to the CCF was from 
the capsular branches of the right cavernous ICA [Fig 1] 
and a few tiny feeders from the right External Carotid 
Artery [ECA] [Fig 2]. Its venous drainage was into the 
cavernous sinus and superior ophthalmic vein. Based on 
the angiographic findings a vessel reconstructive 
approach using a covered stent was planned. Abbott 
Vascular Jostent Grafmaster is a low profile stent system 
constructed using a sandwich technique with an ultra-
thin expandable Polytetrafluoroethylene (PTFE) placed 
between the two stainless steel Jostent stents. The 
patient was systemically heparinized and serial ACTs were 
obtained at regular intervals.  A 0.014 mm BMW microw-
ire was navigated into a distal branch of right middle 
cerebral artery. Under road map guidance, a Jostent 
Graftmaster 3.5 mm x 16mm was advanced and the 
orifice of the fistula was bridged.  Immediate post stent 
angiography confirmed accurate stent placement but 
stent endoleak was noticed. The stent was post dilated to 
stop or further reduce the endoleak using UltraSoft 
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5.0x20x153cm angioplasty balloon. Then, Microvention 
Headway 17 micro catheter was advanced over BMW 
0.014mm microwire and its tip positioned into the right 
internal maxillary arterial fistulous feeder branch to the 
right CCF. The branch was intentionally sacrificed using 
0.5cc of approximately 33% diluted n-butyl cyanoacr-
ylate [n-BCA] glue. Post procedure angiography demon-
strated complete obliteration of the right ECA branch 
arterial feeders to the right CCF and mild stent endoleak 
with angioghraphically-reduced flow in the Right CCF [Fig 
3]. The patient recovered from anesthesia uneventfully 
and reported improvement with his vision and reduction 
in exophthalmos. He was instructed to continue dual 
antiplatelet therapy for 6 months to avoid thrombosis 
and in-stent stenosis. Patient’s six-month follow-up 
angiography showed complete obliteration of the right 
CCF [Fig 4]. The clinical follow-up assessment was 
graded as near full recovery with improving residual mild 
chemosis and exophthalmos. 
 
Fig 1: Selective Right ICA angiography [Oblique view] 
showing indirect Right CCF. 
DISCUSSION
The first therapeutic modality for CCFs currently is the 
Endovascular embolization because it is associated with 
high occlusion and low complication rates. The endovas-
cular therapeutic modalities for CCFs involve the use of 
different embolic materials including detachable 
balloons, silk, coils, n-butyl cyanoacrylate (n-BCA), 
covered stents, and Onyx. In our experience, we found 
the use of a covered stent as a feasible therapeutic 
option for indirect CCF. The final angiogram showed 
complete occlusion of the fistula without recanalization 
and parent artery patency without in-stent stenosis. 
Indirect CCFs are also called dural fistulas and harbor 
low flow rate. Such fistulas can be approached via trans-
venous and transarterial routes.  In the transvenous 
approach the abnormal cavernous sinus is superselec-
tively catheterized to occlude the fistula without compro-
mising the venous drainage (1,3, 13). The technical 
challenge to the transvenous approach includes venous 
perforation. Depending on venous route chosen can be 
fatal if the brainstem is involved. The transarterial 
technique involves catherization of the ECA arterial feed-
ers followed by satisfactory occlusion using liquid 
embolic agents [n-BCA, EVOH, Onyx]. Other therapeutic 
modalities include detachable balloon [DB] occlusion of 
the CCF (14, 17). Residual or recurrent CCF and pseu-
doaneurysm formation is major complication associated 
with DBs. Coil embolization is another alternative 
approach to occlude these fistulas. It was entertained in 
our case but was not considered feasible because of 
high cost and non-availability of surgical expertise to 
acquire direct supra orbital access via the superior 
ophthalmic vein. Covered stents have been used in a 
vast array of cerebrovascular disorders including aneu-
rysms, dissection, pseudoaneurysm and CCFs (8-11, 
18-21). The technically important and challenging factor 
is the complete closure of the fistula orifice. The draw-
backs include CCF recurrence and endoleak that does 
not occur if the orifice is completely closed. In our case, 
the covered stent could be delivered safely. 
Fig 2: Selective Right ECA Angiography [Anteroposterior 
view] showing an arterial feeder to the Right CCF. 
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As such, stents are not readily available in Pakistan. 
Hence, we had to rely on the slightly smaller diameter 
stent followed by post deployment larger diameter 
balloon angioplasty. Post angioplasty, the degree of 
endoleak improved.  Even though the patient symptoms 
were improving but he was brought back for a second 
attempt to deliver a larger diameter stent at four months 
but the stent navigation through the previously deployed 
stent was technically challenging and the procedure was 
aborted. 
Fig 3: Immediate post stenting angiography showing 
markedly reduced flow secondary to stent endoleak into 
the Right CCF. 
He was instructed to switch to a single antiplatelet 
agent. At Six months follow-up, angiography showed 
complete occlusion of the CCF. Neuroendovascular 
therapy in a country like Pakistan with fragile economy 
brings  additional challenges such as a scarcity of neuro-
interventional disposables due to problems with the 
import of these expensive materials and the necessity to 
succeed in completely embolizing a given CCF, aneurysm 
etc. to justify the costs involved. Training of specialists 
remains a difficult task due to the scarcity of both mate-
rials and physician tendency to start self-learning these 
high risk procedures without professional oversight. In 
conclusion, our initial experience of using a covered 
stent to treat CCF in Pakistan indicates procedural feasi-
bility, increased occlusion and anatomic cure rates, 
elimination of the mass effect and reduced cost of treat-
ing such fistulas without compromising the parent 
vessel. Long term clinical follow-up studies are needed. 
Fig 4: Six-Month follow-up angiography showing complete 
obliteration of the right CCF. 
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